口服地塞米松与甲泼尼龙递减方案在全膝关节置换术后疼痛与康复中的比较
该非随机前瞻性队列研究纳入350例初次单侧全膝关节置换术患者,200例接受口服地塞米松,150例接受口服甲泼尼龙递减方案。甲泼尼龙组在术后第3至7天及第9天报告的疼痛评分显著低于地塞米松组(均P<0.05),但至第30天无显著差异;两组在口服吗啡毫克当量(MME)、住院时长、关节活动度、并发症及再入院方面均无统计学显著差异。
要点
- 甲泼尼龙递减方案在术后第3至7天及第9天疼痛评分显著低于地塞米松。
- 两组术后第一个月内麻醉药品消耗量(MME)无统计学显著差异。
- 住院时长、关节活动度、并发症及再入院率两组均无差异。
核心结论
- 接受甲泼尼龙递减方案的患者报告的全膝关节置换术后疼痛评分显著低于接受地塞米松的患者。
- 两组麻醉药品MME及并发症率相似,甲泼尼龙临床结局相似且可能因递减方案更易处方和依从而更受青睐。
研究设计与样本
- 非随机前瞻性队列研究,纳入350例初次单侧全膝关节置换术患者,200例接受口服地塞米松,150例接受口服甲泼尼龙递减方案。
- 主要结局为术后前30天患者记录的疼痛水平(视觉模拟量表)和麻醉药品消耗量(转换为口服吗啡毫克当量MME),并收集住院时长、膝关节活动度、并发症及再入院。
主要发现
- 甲泼尼龙组在术后第3至7天及第9天报告的疼痛显著低于地塞米松组(均P<0.05),至第30天无显著差异。
- 两组术后第一个月内MME无统计学显著差异。
- 两组住院时长、关节活动度、并发症及再入院均无差异。
关键数值与推荐
- 甲泼尼龙组在术后第3至7天及第9天疼痛评分显著低于地塞米松组(均P<0.05)。
- 两组术后第一个月内MME无统计学显著差异。
- 两组住院时长、关节活动度、并发症及再入院无差异。
临床怎么用
- 全膝关节置换术后可考虑使用甲泼尼龙递减方案以改善术后早期疼痛,其递减方案可能更易处方且患者依从性更好。
- 地塞米松与甲泼尼龙在麻醉药品消耗及并发症方面相似,选择时可综合考虑给药便利性和患者依从性。
局限性
- 研究为非随机设计,可能存在选择偏倚。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic corticosteroids are playing an increasingly important role in elective total knee arthroplasty (TKA) to aid in postoperative recovery. Corticosteroids reduce inflammation that can cause pain, limit range of motion (ROM), and prolong narcotic use following TKA. Dexamethasone and methylprednisolone are corticosteroids used perioperatively during TKA, but, to our knowledge, a comparative analysis assessing pain and narcotic use has not been done. We sought to determine if a difference exists between these two medications in reducing pain and narcotic usage while also assessing clinical outcomes and complications. METHODS: A nonrandomized prospective cohort study was performed of 350 patients undergoing primary unilateral TKA; 200 patients received an oral dexamethasone, and 150 patients received an oral methylprednisolone taper. The primary outcome measures included pain levels and narcotic consumption recorded by patients over the first 30 days after surgery. Pain scores were implemented utilizing the visual analog scale. Narcotic usage was converted to oral morphine milligram equivalents (MMEs). Lengths of hospital stay, knee ROMs, complications, and hospital readmissions were collected. RESULTS: Patients taking methylprednisolone reported significantly lower pain than patients taking dexamethasone on postoperative days three to seven and nine (all P < 0.05), with no significant differences through day 30. There were no statistically significant differences in MMEs between groups during the first postoperative month. There were no differences in lengths of stay, ROMs, complications, or hospital readmissions. CONCLUSIONS: A novel prospective study is presented comparing dexamethasone versus methylprednisolone, assessing narcotic usage and pain scores following TKA. Patients who received methylprednisolone taper reported statistically significantly lower postoperative pain scores compared to those receiving dexamethasone. Narcotic MMEs and complication rates were similar. Methylprednisolone demonstrated similar clinical outcomes and may be preferred for its more controlled tapering profile and greater ease of prescription and patient compliance than dexamethasone.
引用
- Tye EY, Forslund JM, Kackman RM, et al. Oral Dexamethasone Versus Methylprednisolone Taper for Postoperative Pain and Recovery After Total Knee Arthroplasty. J Arthroplasty. 2026. PMID: 41932405. doi:10.1016/j.arth.2026.03.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。